Sionna Therapeutics targets cystic fibrosis with novel CFTR/NBD1 stabilization; key 2026 readouts and cash runway to 2028.

Beauty's next frontier isn't a product, it's brain health, with science-backed rituals reshaping skincare and a wellness ...

High blood pressure can speed up kidney damage. Here’s how managing blood pressure with IgA nephropathy protects your filters ...

The Transportation Security Administration is initiating a new screening program for crew members, and airlines are paying ...

A road repair program designed for holistic city reconstruction was called into question by councilors Monday at a public works committee meeting in council chambers, 50 Town Square, Lima. If ...

In this episode of Aging Untold, we examine the shift many people feel in their 70s, when priorities change and living with ...

Researchers found that World Trade Center responders with PTSD showed molecular changes associated with faster biological aging and an increased risk of chronic illness.

Taysha Gene Therapies (TSHA) remains a Buy on strong TSHA-102 Rett data, FDA-aligned pivotal path, and cash to 2028—read the ...

Daniel Belavy, a professor of physical therapy at Bochum University of Applied Sciences in Germany, has spent much of his ...

The U.S. Army veteran-operated maker of advanced photonic solutions will support U.S. Army's night fighting capability ...

This car safety system could save your life, but right now it could be locked behind a subscription requiring you to pay an ...

Showcase your company news with guaranteed exposure both in print and online Join us for an unforgettable evening of inspiration and empowerment at the Outstanding Women in… Tech Tomorrow 2026 offers ...